Form D · Other Health Care
HighRes Biosolutions, Inc.
Woburn, MA · CIK 0001648720
Offering snapshot reported Jul 21, 2015 · SEC filing
- Reported sold
- $2.48M Offering amount: $2.48M
- Investors reported
- 1 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Jul 8, 2015 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Jul 21, 2015 | Initial | $2,482,728 | No comparison | 1 | SEC filing |
Offering details
- Securities
- Equity
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-244136
Source: Form D, filed Jul 21, 2015. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Louis Guarracina | Director, Executive |
| Peter Harris | Director |
| Matthew Kiley | Executive |
| Michael Milligan | Director |
Issuer details
Industry: Other Health Care (See others in industry)
Address:
299 Washington Street
Woburn, MA, 01801
Woburn, MA, 01801